http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP10010053-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5226f8ad530610dd4201fdcc20eeea12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222 |
| filingDate | 2010-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d95a0088648bda38a01e5ba16db78f4f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44b05e3cf6d7118d21de302f374d0fa7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55144af93f52f24ef2a4927994c00ac9 |
| publicationDate | 2010-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EC-SP10010053-A |
| titleOfInvention | PHARMACEUTICAL COMPOSITION COMPOSED BY THE COMBINATION OF CONDROITIN AND DIACEREINE SULFATE AND ITS USE IN THE TREATMENT OF OSTEOARTRITIS AND RELATED DISEASES |
| abstract | The present invention relates to a pharmaceutical composition composed of the synergistic combination of an antiarthritic agent, known as: Chondroitin Sulfate and an Interleukin-1 inhibitor, known as: Diacerein, in addition to pharmaceutically acceptable excipients, which are found formulated in a single dose unit to be administered orally, useful for the control and treatment of Osteoarthritis and related diseases, which provides a greater therapeutic effect, a greater rapidity of pharmacological action in less time, with pain reduction, inflammation and modification of the course of structural disease of articular cartilage, as well as lower risks of presenting severe complications and / or side effects. |
| priorityDate | 2007-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.